Enfusion Q1 2024 earnings announced; press release details not available in filing

Enfusion, Inc.

2024-Q1 EPS reported -$0.01 revenue$48,052,000

Press release issued May 9, 2024 announces Q1 2024 financial results.
Exhibit 99.1 text appears as 'PROPRIETARY AND CONFIDENTIAL' without detailed results.
Specific financial figures and guidance are not provided in the filing excerpt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Enfusion, Inc. reported financial results for the fiscal quarter ended March 31, 2024.

Period: the fiscal quarter ended March 31, 2024
Result: reported results

Exact text from the filing

On May 9, 2024, Enfusion, Inc. announced its financial results for the fiscal quarter ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

View on SEC.gov

1050 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001558370-24-007471

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.